TrialJournal of radiation research2024

Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.

Motohiro Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.